<DOC>
	<DOCNO>NCT01986582</DOCNO>
	<brief_summary>Allergic rhinitis treat variety systemic locally apply drug . The effectiveness intranasally applied formulation diminish clean mechanism nose , rhinorrhea particular . Slowing clearance nasal mucosa prolong contact time locally apply drug nasal mucosa would improve efficacy . One method create dosage form contain mucoadhesive polymer . We demonstrate mucoadhesive solution contain HPMC enhances clinical efficacy oxymetazoline . However , industrial development fix combination pharmaceutical compound mucoadhesive carrier require substantial investment , escalate manifold different pharmaceutical compound render mucoadhesive . NoAl cellulose derivative powder , form gel layer contact mucosal surface nose block contact pollen grain nasal mucosa seasonal allergic rhinitis . However , another potential benefit apply NoAl ( HPMC ) along commercially available drug local treatment rhinitis , formation gel layer substantially delay clearance nose thus increase effectiveness . This hypothesis need substantiate clinically .</brief_summary>
	<brief_title>NoAL ( HPMC ) Combination With Oxymetazoline Patients With Allergic Rhinitis</brief_title>
	<detailed_description>The main objective trial test synergy HPMC oxymetazoline ( apply nasally ) increase peak nasal inspiratory flow patient suffer moderately severe / severe persistent allergic rhinitis . The design trial parallel-groups , double blind , randomize , placebo control , single centre study . Forty patient randomly assign receive either oxymetazoline follow HPMC ( Group A ) oxymetazoline follow placebo ( Group B ) . Each patient follow 15 day . Day 1 screen inclusion visit . Data collect day 8 &amp; 15 . Patients fill diary everyday symptom , adverse event apply medication .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<criteria>Male female patient Age ≥ 18 ≤ 50 year Moderately severe / severe persistent allergic rhinitis Positive skin prick test perennial aeroallergens Active symptom prominent congestion time inclusion Subjects pollen sensitization respective pollen season Subjects arterial hypertension , arrhythmia evidence heart ischemia Subjects serious chronic comorbidities bad therapeutic control Subjects nasal polyposis Flulike episode past 30 day Subjects unable give inform consent Subjects contraindication oxymetazoline NoAL Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Congestion</keyword>
	<keyword>Mucoadhesive Treatment</keyword>
	<keyword>Nasal Decongestant</keyword>
</DOC>